Hematopoiesis-related microRNA expression in myelodysplastic syndromes

Leukemia and Lymphoma

Volumn 50, Issue 11, 2009, Pages 1854-1859

  Pons, Aina ^a   Nomdedeu, Benet ^b   Navarro, Alfons ^a   Gaya, Anna ^b   Gel, Bernat ^a   Diaz, Tania ^a   Valera, Sandra ^b   Rozman, Mara ^b   Belkaid, Mohamed ^b   Montserrat, Emili ^b   Monzo, Mariano ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Hematopoiesis; MDS; MicroRNA; MiR 181a; MiR 222; Post MDS AML

Indexed keywords

MICRORNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLOOD; BONE MARROW; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BONE MARROW; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIESIS; HUMANS; LEUKEMIA, MYELOID; MALE; MICRORNAS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 71049175699     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428190903147645     Document Type: Article

References (31)

1. Heaney ML, Golde DW. Myelodysplasia. N Engl J Med 1999;340:1649-1660.
2. Germing U, Strupp C, Kundgen A, et al. No increase in agespecific incidence of myelodysplastic syndromes. Haematologica 2004;89:905-910.
3. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-199.
4. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002;100:2292-2302.
5. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079-2088.
6. Cazzola M, Malcovati L. Myelodysplastic syndromes - coping with ineffective hematopoiesis. N Engl J Med 2005;352:536-538.
7. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
8. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001;294:853-858.
9. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259-269.
10. Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006;25:6188-6196.
11. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004;101:2999-3004.
12. Chen CZ, Li L, Lodish HF, Bartel DP.MicroRNAs modulate hematopoietic lineage differentiation. Science 2004;303: 83-86.
13. Monticelli S, Ansel KM, Xiao C, et al. MicroRNA profiling of the murine hematopoietic system. Genome Biol 2005;6: R71.
14. Ramkissoon SH, Mainwaring LA, Ogasawara Y, et al. Hematopoietic-specific microRNA expression in human cells. Leuk Res 2006;30:643-647.
15. Felli N, Fontana L, Pelosi E, et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 2005; 102:18081-18086.
16. Fazi F, Rosa A, Fatica A, et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/ EBPalpha regulates human granulopoiesis. Cell 2005;123: 819-831.
17. Garzon R, Pichiorri F, Palumbo T, et al. MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA 2006;103:5078-5083.
18. Georgantas RW III, Hildreth R, Morisot S, et al. CD34t hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci USA 2007;104:2750-2755.
19. Navarro A, Gaya A, Martinez A, et al. MicroRNA expression profiling in classic Hodgkin lymphoma. Blood 2008;111: 2825-2832.
20. Yoshida Y, Mufti GJ. Apoptosis and its significance in MDS: controversies revisited. Leuk Res 1999;23:777-785.
21. He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature 2005;435: 828-833.
22. Woods K, Thomson JM, Hammond SM. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 2007;282:2130-2134.
23. Taguchi A, Yanagisawa K, Tanaka M, et al. Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17- 92 microRNA cluster. Cancer Res 2008;68:5540-5545.
24. Lu Z, Liu M, Stribinskis V, et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008;27:4373-4379.
25. Connolly E, Melegari M, Landgraf P, et al. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol 2008;173:856-864.
26. Flores-Figueroa E, Gutierrez-Espindola G, Montesinos JJ, rana-Trejo RM, Mayani H. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome. Leuk Res 2002;26:677-686.
27. Micheva I, Thanopoulou E, Michalopoulou S, et al. Defective tumor necrosis factor alpha-induced maturation of monocytederived dendritic cells in patients with myelodysplastic syndromes. Clin Immunol 2004;113:310-317.
28. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NFkappaB- dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006;103: 12481-12486.
29. Debernardi S, Skoulakis S, Molloy G, Chaplin T, xon-McIver A, Young BD. MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 2007;21:912-916.
30. Marcucci G, Radmacher MD, Maharry K, et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008;358:1919-1928.
31. Pfeilstocker M, Karlic H, Nosslinger T, et al. Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implications. Leuk Lymphoma 2007;48: 1900-1909.